Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Positron-Emission Tomography”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01244737
What this trial is testing

FLT-PET Imaging of Brain Tumors in Children

Who this might be right for
Brain Neoplasms
Frederick Daniel Grant 50
Testing effectiveness (Phase 2)Study completedNCT07209865
What this trial is testing

68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

Who this might be right for
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University 82
Not applicableStudy completedNCT06370234
What this trial is testing

The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.

Who this might be right for
Breast CancerChemotherapy EffectDiffusion Weighted MRI+2 more
National Taiwan University Hospital 60
Very early researchStudy completedNCT00620243
What this trial is testing

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00721799
What this trial is testing

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

Who this might be right for
Mouth NeoplasmsOropharyngeal NeoplasmsLaryngeal Neoplasms+1 more
University of Iowa 33
Not applicableStudy completedNCT01235052
What this trial is testing

Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer

Who this might be right for
Cancer of Head and NeckHead and Neck Neoplasms
University Hospital, Bordeaux 16
Not applicableStudy completedNCT01320852
What this trial is testing

PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
McGill University Health Centre/Research Institute of the McGill University Health Centre 100
Very early researchUnknownNCT05691855
What this trial is testing

89Zr-labeled NY009 PET Imaging in Patients

Who this might be right for
Cancer
Affiliated Hospital of Jiangnan University 10
Not applicableUnknownNCT03570866
What this trial is testing

PET/CT in the Management of Patients With Early Stage Endometrial Cancer

Who this might be right for
Endometrium Cancer
Università degli Studi dell'Insubria 40
Not applicableLooking for participantsNCT02641145
What this trial is testing

Molecular Imaging of Primary Amyloid Cardiomyopathy

Who this might be right for
Amyloidosis, PrimaryCardiomyopathy
Brigham and Women's Hospital 171
Not applicableStudy completedNCT00499395
What this trial is testing

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4
Not applicableStudy completedNCT05924282
What this trial is testing

PET on Surgery for Loco-regionally Recurrent Colorectal Cancer

Who this might be right for
PET-driven SurgeryLoco-regional Recurrent Colorectal Cancer
National Taiwan University Hospital 193
Not applicableStudy completedNCT02175095
What this trial is testing

[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

Who this might be right for
Colorectal Cancer
Asan Medical Center 68
Testing effectiveness (Phase 2)Study completedNCT05653856
What this trial is testing

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate (Disorder)
Curium US LLC 26
Not applicableUnknownNCT01089244
What this trial is testing

FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma

Who this might be right for
AstrocytomaOligoastrocytomaOligodendroglioma
Ludwig-Maximilians - University of Munich 38
Early research (Phase 1)Ended earlyNCT05096234
What this trial is testing

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Stanford University 2
Very early researchEnded earlyNCT00414570
What this trial is testing

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Who this might be right for
Pancreatic Cancer
AHS Cancer Control Alberta 11
Not applicableStudy completedNCT02061345
What this trial is testing

PET Imaging in MCI Following ADT for PCa

Who this might be right for
Prostate CancerMild Cognitive Impairment
Imperial College London 11
Not applicableLooking for participantsNCT06335914
What this trial is testing

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Looking for participantsNCT04824014
What this trial is testing

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

Who this might be right for
ER+ Breast Cancer
Centre de recherche du Centre hospitalier universitaire de Sherbrooke 150
Next Page